Why FDA can’t disclose the first coronavirus-related drug shortage

Around 10 PM ET last night, the FDA said that it is aware of a drug shortage related to an active pharmaceutical ingredient (API) manufacturer affected by the coronavirus, but the agency stopped short of revealing what drug it is.